Continuing candidates definition

Continuing candidates means candidates not elected or not excluded from the poll at any given time.
Sample 1Sample 2Sample 3
Continuing candidates means candidates not elected or not excluded from the poll at any given time;
Sample 1Sample 2

Examples of Continuing candidates in a sentence

  • FMI4.3 Continuing candidates must reregister by no later than February.

  • FMP4.3 Continuing candidates must reregister by no later than February.

  • Continuing candidates in certain subject areas may be liable for bench fees.

  • Continuing candidates are liable only for the continuation fee: Usual tuition fees do not apply during this period.

  • Communications liaison • convene meetings of program faculty as needed for consultation • advise school director on issues relating to the program • represent the program at program chair meetings • circulate information about conferences, fellowships, etc.

  • One State launched a unilateral monitoring mechanism that began reporting on, and evaluating the response of other States to, the issue of trafficking in persons.

  • Those entering the candidacy process.3. Continuing candidates whose tests are over 5 years old.4. Appointed clergy, lay pastors, and certified lay ministers, who are referred by the Cabinet, The Board of Ministry and/or The Committee on Conference Relations.5. Appointed clergy, lay pastors, and certified lay ministers who personally request evaluations for personal issues and/or growth reasons.

  • Continuing candidates register directly on the university system: http://webstar.nova.edu.

  • ETHICS OF SELLING ARTIFACTS The proceeds for the sale of any deaccessioned artifact or unwanted donations must be invested back into the existing collection from which it came.

  • Continuing candidates who have concerns over choosing comprehensive examination or thesis track and future career-related options will also benefit from their interactions with candidates exiting from the program.

Related to Continuing candidates

  • continuing candidate means any candidate not deemed to be elected, and not excluded,

  • Replacement Candidate means any Candidate Introduced by the Agency to the Client to fill the Engagement following the Introduction of another Candidate whose Engagement either did not commence or was terminated during the first 12 weeks of the Engagement;

  • KPI Target means the acceptable performance level for a KPI as set out in each KPI;

  • Product Candidate means each of MYO-101, MYO-102, MYO-103, MYO-201 and MYO-301, as defined on Exhibit B, in each case in any form or formulation.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Soft Target means a target that will suffer minimum damage and cause minimum damage to the subject vehicle in the event of a collision.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Acquisition Target means any Person becoming a Subsidiary of the Company after the date hereof; any Person that is merged into or consolidated with the Company or any Subsidiary of the Company after the date hereof; or any Person with respect to which all or a substantial part of that Person’s assets are acquired by the Company or any Subsidiary of the Company after the date hereof.

  • Independent candidate means any candidate who claims not to be affiliated with a political party, and whose name has been certified on the office-type ballot at a general or special election through the filing of a statement of candidacy and nominating petition, as prescribed in section 3513.257 of the Revised Code.

  • Alternative nicotine product means any vaping product, whether or not it includes nicotine, including electronic smoking devices, that can be ingested into the body by chewing, smoking, absorbing, dissolving, inhaling, or by any other means. ‘Alternative nicotine product’ does not include:

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Development Milestone Event shall have the meaning set forth in Section 9.2(a).

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Licensed Compound means (a) 3,4-Diaminopyridine, the chemical structure of which is set forth on Exhibit B-2; and (b) any derivatives, isomers, metabolites, prodrugs, acid forms, base forms, salt forms, or modified versions of such compound in (a).

  • USP-NF means the current edition of the United States Pharmacopeia-National Formulary.

  • Product Conditions means these product terms and conditions. These Product Conditions apply to each series of cash settled Warrants over single equities;

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Milestone Event has the meaning set forth in Section 8.4.

  • Pivotal Clinical Trial means a pivotal human clinical trial of a Licensed Product with a defined dose or a set of defined doses of such Licensed Product designed to ascertain efficacy and safety of such Licensed Product for the purpose of enabling the preparation and submission of an MAA to the competent Regulatory Authorities in a country of the Territory, as further defined in 21 C.F.R. § 312.21(c) for the U.S., as amended from time to time, or the corresponding foreign regulations.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.